0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThis real-world study provides evidence that measurement of early serum ustekinumab levels could be useful to direct the treatment strategy for psoriasis. Adequate drug exposure early in the treatment cycle may be particularly important in determining clinical outcome.
Teresa Tsakok, Nina Wilson, Nick Dand, Floris C. Loeff, Karien Bloem, David Baudry, Michael Duckworth, Shan Pan, Angela Pushpa‐Rajah, Joseph F. Standing, Annick de Vries, Ali Alsharqi, G Becher, Ruth Murphy, Shyamal Wahie, Andrew Wright, Christopher Em Griffiths, Nick J. Reynolds, Juliet N. Barker, Richard B. Warren, A. David Burden, Theo Rispens, Deborah Stocken, Catherine Smith (2019). Association of Serum Ustekinumab Levels With Clinical Response in Psoriasis. , 155(11), DOI: https://doi.org/10.1001/jamadermatol.2019.1783.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2019
Authors
24
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1001/jamadermatol.2019.1783
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
.webp){kind=avatar}
